Alpha-synuclein and the prion hypothesis in Parkinson's disease

被引:26
|
作者
Melki, R. [1 ]
机构
[1] CNRS, Lab Neurodegenerat Dis, CEA, Inst Francois Jacob,MIRCen, 18 Route Panorama, F-92265 Fontenay Aux Roses, France
基金
欧盟地平线“2020”;
关键词
Alpha-synuclein; Parkinson's disease; Multiple system atrophy; Dementia with Lewy bodies; prion-like propagation; PACKING DEFECTS; OLFACTORY-BULB; CELL-DEATH; MEMBRANE; FIBRILS; PATHOLOGY; MUTATION; TRANSMISSION; NEURONS; BRAIN;
D O I
10.1016/j.neurol.2018.08.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Protein intracellular inclusions within the central nervous system are hallmarks of several progressive neurodegenerative disorders in man. The protein constituents of those deposits and the affected regions within the brain differ from one neurodegenerative disorder to another. Until recently, the vicious circle consisting of spread, seeded assembly and accumulation over time within the central nervous system of misfolded proteins aggregates was thought to be restricted to the prion protein PrP. Recent reports suggest that other protein aggregates spread and amplify within the central nervous system leading to distinct diseases. How alpha-synuclein protein assemblies traffic between cells, amplify by recruiting endogenous monomeric alpha-synuclein and cause distinct synucleinopathies is unclear. I review here the experimental evidence supporting the propagation of alpha-synuclein mega-dalton assemblies in a manner similar to prion protein aggregates. I also describe how alpha-synuclein aggregates. I also explain why the aggregation of alpha-synuclein may lead to distinct synucleinopathies. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 50 条
  • [1] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [2] Alpha-synuclein and Parkinson's disease
    C. B. Lücking
    A. Brice*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1894 - 1908
  • [3] Alpha-synuclein and Parkinson's disease
    Lücking, CB
    Brice, A
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) : 1894 - 1908
  • [4] Somatic alpha-synuclein mutations in Parkinson's disease: Hypothesis and preliminary data
    Proukakis, Christos
    Houlden, Henry
    Schapira, Anthony H.
    MOVEMENT DISORDERS, 2013, 28 (06) : 705 - 712
  • [5] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [6] Role of Alpha-Synuclein in Parkinson's Disease
    Link, Tina
    Maraghi, Sophie
    Reddy, Megan
    Sheth, Heli
    Stark, Kaylan
    Vijay, Varun
    FASEB JOURNAL, 2021, 35
  • [7] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [8] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966
  • [9] Transmission of alpha-synuclein in Parkinson’s disease
    Virginia M-Y Lee
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [10] Alpha-Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari
    Stewart, Tessandra
    Zhang, Jing
    BRAIN PATHOLOGY, 2016, 26 (03) : 410 - 418